Chemical Compound
Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-; Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]- (7CI,8CI); 1-(ss-Morpholinoethyl)-5-nitroimidazole; 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine; Acterol; Esclama; K-1900; NSC 107524; Naxofem; Naxogin; Nimorazol; Nimorazole; Nitrimidazine; Nulogyl
CAS Registry Number
6506-37-2
Primary record
Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-; Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]- (7CI,8CI); 1-(ss-Morpholinoethyl)-5-nitroimidazole; 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine; Acterol; Esclama; K-1900; NSC 107524; Naxofem; Naxogin; Nimorazol; Nimorazole; Nitrimidazine; Nulogyl
- 库存
- 2,219 克
- 纯度
- 98.5 %
- CAS
- 6506-37-2
化合物标识与属性
- CAS
- 6506-37-2
- PubChem CID
- 23009
- SMILES
- C1COCCN1CCN2C=NC=C2[N+](=O)[O-]
- Canonical SMILES
- O=[N+]([O-])c1cncn1CCN1CCOCC1
名称与同义词
- Nimorazole
- Naxogin
- Nitrimidazine
- Nimorazol
- Nulogyl
- Esclama
- Naxofem
- Acterol
- Nimorazolo
- 6506-37-2
- Acterol forte
- Nimorazolum
- Sirledi
- Nimorazole?
- Nimorazolo [DCIT]
- 4-(2-(5-Nitro-1H-imidazol-1-yl)ethyl)morpholine
- Nimorazole (INN)
- Naxogin (TN)
- Nimorazol [INN-Spanish]
- Nimorazolum [INN-Latin]
- Naxogin 500
- Nimorazole [BAN:INN]
- Nimorazole [INN:BAN]
- Nimorazole (Standard)
- NIMORAZOLE [MI]
- 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine
- DTXSID1057795
- N-2-Morpholinoethyl-5-nitroimidazole
- AC1L2LGX
- K-1900
- NIMORAZOLE [INN]
- RefChem:165953
- 469ULX0H4G
- UNII-469ULX0H4G
- C9H14N4O3
- MLS002703984
- NIMORAZOLE [MART.]
- MDJFHRLTPRPZLY-UHFFFAOYSA-N
- NIMORAZOLE [WHO-DD]
- SCHEMBL21836
- DTXCID2031584
- 1-(2-N-Morpholinylethyl)-5-nitroimidazole
- NSC 107524
- NSC-107524
- EINECS 229-394-4
- MFCD00866796
- CHEMBL435966
- orb1306650
- orb3025272
- K 1900
- 1-(beta-Morpholinoethyl)-5-nitroimidazole
- 1-(N-p-Ethylmorpholine)-5-nitroimidazole
- AOB6012
- BRN 0533758
- MSK5558
- P01AB06
- 4-(2-(5-Nitroimidazol-1-yl)ethyl)morpholine
- CHEBI:134929
- GLXC-05724
- HMS5085C20
- 4-[2-(5-Nitro-1H-imidazol-1-yl)ethyl]morpholine
- Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-
- BCP11055
- CID23009
- GAA50637
- Tox21_113897
- 4-(2-(5-Nitroimidazol-1-yl)ethyl)-morpholine
- C9-H14-N4-O3
- CID:23009
- HY-16349R
- MFCD00213940
- MSK5558-100M
- NSC107524
- s6411
- ZINC26167988
- AKOS022174968
- AN-2334
- CS-2854
- CS-W-00181
- DB12172
- J8.420D
- Morpholine, 4-(2-(5-nitro-1H-imidazol-1-yl)ethyl)-
- 1-(.beta.-Morpholinoethyl)-5-nitroimidazole
- K1900
- NCGC00261977-01
- AC-35227
- AJ-82204
- AM807557
- AS-31120
- DA-21636
- HY-16349
- K057
- LS-93226
- Morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)-
- SC-16175
- SMR001570693
- CAS-6506-37-2
- SID:125240960
- WLN: T6N DOTJ A2- AT5N CNJ ENW
- AB0014002
- Nimorazole Solution in Methanol, 100ug/mL
- FT-0710009
- NS00006047
- 1-(3-ethyl-2,6-dihydroxyphenyl)ethan-1-one
- Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]-
- 4-[2-(5-Nitro-1-imidazolyl)ethyl]-morpholine
- A13091
- D07352
- 506N372
- A834961
- D009554
- Q7037737
- 4-[2-(5-Nitro-1H-imidazol-1-yl)ethyl]morpholine #
- BRD-K79145628-001-05-5
- 229-394-4
- Esclama|||K-1900|||Naxogin|||Nitrimidazine|||Nulogyl|||4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine
- Morpholine, 4-[2-(5-nitro-1H-imidazol-1-yl)ethyl]-; Morpholine, 4-[2-(5-nitroimidazol-1-yl)ethyl]- (7CI,8CI); 1-(ss-Morpholinoethyl)-5-nitroimidazole; 4-[2-(5-Nitroimidazol-1-yl)ethyl]morpholine; Acterol; Esclama; K-1900; NSC 107524; Naxofem; Naxogin; Nimorazol; Nimorazole; Nitrimidazine; Nulogyl